Data:
{
"symbol": "NVO",
"price": 36.94,
"marketCap": 164036076177,
"beta": 0.349,
"lastDividend": 1.16351,
"range": "35.12-64.16",
"change": -0.6,
"changePercentage": -1.5983,
"volume": 2935987,
"averageVolume": 12616204,
"companyName": "Novo Nordisk A/S",
"currency": "USD",
"cik": "0000353278",
"isin": "US6701002056",
"cusip": "670100205",
"exchangeFullName": "New York Stock Exchange",
"exchange": "NYSE",
"industry": "Drug Manufacturers - General",
"website": "https://www.novonordisk.com",
"description": "Novo Nordisk A/S is a global pharmaceutical firm dedicated to the investigation, creation, manufacturing, and distribution of medicinal products across a vast international footprint. Its market presence extends throughout Europe, the Middle East, Africa, various parts of Asia (including Mainland China, Hong Kong, and Taiwan), and North America. The company's operations are structured into two principal business units: Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity Care division delivers therapies for diabetes, obesity, cardiovascular ailments, and other emerging therapeutic areas. Meanwhile, the Rare Disease division concentrates on providing treatments for rare blood disorders, uncommon endocrine conditions, and hormone replacement solutions. In addition to its core pharmaceutical offerings, Novo Nordisk produces specialized medical equipment such as insulin pens, growth hormone pens, and injection needles. It also pioneers smart digital solutions for diabetes management, including advanced insulin pens and the Dose Check application, designed to guide insulin dosage. The company engages in strategic alliances, notably a partnership with UNICEF to combat childhood obesity and a collaboration with Valo Health, Inc. to discover and advance novel drug pipelines in the cardiometabolic space. Founded in 1923, Novo Nordisk A/S is headquartered in Bagsvaerd, Denmark.",
"ceo": "Maziar Mike Doustdar",
"sector": "Healthcare",
"country": "DK",
"fullTimeEmployees": "68794",
"phone": "45 44 44 88 88",
"address": "Novo Alle 1",
"city": "Bagsvaerd",
"state": "CR",
"zip": "2880",
"image": "https://images.financialmodelingprep.com/symbol/NVO.png",
"ipoDate": "1981-04-30",
"defaultImage": false,
"isEtf": false,
"isActivelyTrading": true,
"isAdr": true,
"isFund": false
}
Data:
{
"symbol": "NVO",
"name": "Novo Nordisk A/S",
"price": 37.53,
"changePercentage": -0.02663825,
"change": -0.01,
"volume": 13684411,
"dayLow": 36.845,
"dayHigh": 37.53,
"yearHigh": 64.16,
"yearLow": 35.12,
"marketCap": 166656041358,
"priceAvg50": 44.2122,
"priceAvg200": 45.54265,
"exchange": "NYSE",
"open": 37.35,
"previousClose": 37.54,
"timestamp": 1791316802,
"quote_spread": {},
"chart_vwap_daily": [
{
"t": "2026-08-26",
"v": 47.3726,
"c": 47.19
},
{
"t": "2026-08-27",
"v": 46.0739,
"c": 46.26
},
{
"t": "2026-08-28",
"v": 45.7015,
"c": 45.61
},
{
"t": "2026-08-31",
"v": 45.3446,
"c": 45.33
},
{
"t": "2026-09-01",
"v": 45.3651,
"c": 45.12
},
{
"t": "2026-09-02",
"v": 46.6788,
"c": 46.77
},
{
"t": "2026-09-03",
"v": 47.2391,
"c": 47.51
},
{
"t": "2026-09-04",
"v": 46.5028,
"c": 46.6
},
{
"t": "2026-09-08",
"v": 45.383,
"c": 45.16
},
{
"t": "2026-09-09",
"v": 44.8182,
"c": 44.56
},
{
"t": "2026-09-10",
"v": 44.314,
"c": 44.01
},
{
"t": "2026-09-11",
"v": 43.0214,
"c": 43.07
},
{
"t": "2026-09-14",
"v": 43.4287,
"c": 43.45
},
{
"t": "2026-09-15",
"v": 42.6042,
"c": 42.53
},
{
"t": "2026-09-16",
"v": 41.9821,
"c": 41.71
},
{
"t": "2026-09-17",
"v": 42.9764,
"c": 43.19
},
{
"t": "2026-09-18",
"v": 43.2162,
"c": 43.24
},
{
"t": "2026-09-21",
"v": 39.9861,
"c": 39.8
},
{
"t": "2026-09-22",
"v": 39.4568,
"c": 39.4
},
{
"t": "2026-09-23",
"v": 38.4957,
"c": 38.17
},
{
"t": "2026-09-24",
"v": 38.4369,
"c": 38.62
},
{
"t": "2026-09-25",
"v": 38.6468,
"c": 38.8
},
{
"t": "2026-09-28",
"v": 38.5964,
"c": 38.71
},
{
"t": "2026-09-29",
"v": 38.227,
"c": 38.31
},
{
"t": "2026-09-30",
"v": 38.1646,
"c": 37.91
},
{
"t": "2026-10-01",
"v": 37.5716,
"c": 37.4
},
{
"t": "2026-10-02",
"v": 37.3673,
"c": 37.32
},
{
"t": "2026-10-05",
"v": 37.2997,
"c": 37.54
},
{
"t": "2026-10-06",
"v": 37.2707,
"c": 37.53
}
],
"vwap_summary": {
"days": 29,
"days_above": 14,
"days_below": 15,
"pct_days_above": 48,
"position": "above",
"gap_pct": 0.7,
"streak_days": 2
}
}
Data:
{
"volume": 13684411,
"avgVolume": 12616204,
"short_ratio": [
{
"symbol": "NVO",
"file_date": "2026-10-06",
"date": "20261006",
"short_volume": 2256113,
"short_exempt_volume": 25855,
"total_volume": 5449980,
"short_volume_ratio": 0.414,
"signal": "Bullish"
}
],
"volume_profile": {
"poc": 39.82,
"vah": 39.88,
"val": 37.02,
"profile": [
{
"price": 36.95,
"volume": 4362315
},
{
"price": 37.08,
"volume": 6028757
},
{
"price": 37.21,
"volume": 5518714
},
{
"price": 37.34,
"volume": 8830479
},
{
"price": 37.47,
"volume": 9485695
},
{
"price": 37.6,
"volume": 6225611
},
{
"price": 37.73,
"volume": 2197709
},
{
"price": 37.86,
"volume": 508166
},
{
"price": 38.0,
"volume": 3542941
},
{
"price": 38.13,
"volume": 11104740
},
{
"price": 38.26,
"volume": 16631990
},
{
"price": 38.39,
"volume": 12883036
},
{
"price": 38.52,
"volume": 12698549
},
{
"price": 38.65,
"volume": 14555577
},
{
"price": 38.78,
"volume": 6505188
},
{
"price": 38.91,
"volume": 1218472
},
{
"price": 39.04,
"volume": 600992
},
{
"price": 39.17,
"volume": 456077
},
{
"price": 39.3,
"volume": 2986054
},
{
"price": 39.43,
"volume": 8860692
},
{
"price": 39.56,
"volume": 7795662
},
{
"price": 39.69,
"volume": 15370750
},
{
"price": 39.82,
"volume": 18279123
},
{
"price": 39.95,
"volume": 369711
},
{
"price": 40.08,
"volume": 1827815
},
{
"price": 40.21,
"volume": 1093641
},
{
"price": 40.34,
"volume": 1303026
},
{
"price": 40.47,
"volume": 2289364
},
{
"price": 40.6,
"volume": 1139791
},
{
"price": 40.73,
"volume": 0
},
{
"price": 40.86,
"volume": 1944027
},
{
"price": 40.99,
"volume": 0
},
{
"price": 41.12,
"volume": 0
},
{
"price": 41.25,
"volume": 0
},
{
"price": 41.38,
"volume": 0
},
{
"price": 41.51,
"volume": 1059156
},
{
"price": 41.64,
"volume": 1150292
},
{
"price": 41.77,
"volume": 929390
},
{
"price": 41.9,
"volume": 2309287
},
{
"price": 42.03,
"volume": 2403306
},
{
"price": 42.16,
"volume": 1295104
},
{
"price": 42.29,
"volume": 559165
},
{
"price": 42.42,
"volume": 893998
},
{
"price": 42.55,
"volume": 4652466
},
{
"price": 42.68,
"volume": 3662837
},
{
"price": 42.81,
"volume": 3500776
},
{
"price": 42.94,
"volume": 7043103
},
{
"price": 43.07,
"volume": 6738319
},
{
"price": 43.2,
"volume": 6391924
},
{
"price": 43.33,
"volume": 5038329
},
{
"price": 43.46,
"volume": 2870395
},
{
"price": 43.59,
"volume": 1334713
},
{
"price": 43.73,
"volume": 121958
},
{
"price": 43.86,
"volume": 0
},
{
"price": 43.99,
"volume": 1079252
},
{
"price": 44.12,
"volume": 874538
},
{
"price": 44.25,
"volume": 770140
},
{
"price": 44.38,
"volume": 804743
},
{
"price": 44.51,
"volume": 1642207
},
{
"price": 44.64,
"volume": 467326
}
],
"sessions": 20
}
}
Data:
{
"symbol": "NVO",
"marketCap": 1108621228379,
"enterpriseValueTTM": 1204266241936,
"evToSalesTTM": 3.6555947326723954,
"evToOperatingCashFlowTTM": 9.054020617995775,
"evToFreeCashFlowTTM": 24.618562634237584,
"evToEBITDATTM": 6.960110900100564,
"netDebtToEBITDATTM": 0.5527845847974847,
"currentRatioTTM": 0.8729018792636867,
"incomeQualityTTM": 1.1422670319383732,
"grahamNumberTTM": 171.95020209013813,
"grahamNetNetTTM": -50.049468627224705,
"taxBurdenTTM": 0.7828153466577926,
"interestBurdenTTM": 0.9891212554443595,
"workingCapitalTTM": -30387000000,
"investedCapitalTTM": 323428000000,
"returnOnAssetsTTM": 0.19572192872906724,
"operatingReturnOnAssetsTTM": 0.2462340641954942,
"returnOnTangibleAssetsTTM": 0.24624009270772537,
"returnOnEquityTTM": 0.5908675161902104,
"returnOnInvestedCapitalTTM": 0.2972698763840722,
"returnOnCapitalEmployedTTM": 0.3993081510040522,
"earningsYieldTTM": 0.10537617078330722,
"freeCashFlowYieldTTM": 0.0441241776251437,
"capexToOperatingCashFlowTTM": 0.6322278943530137,
"capexToDepreciationTTM": 3.096284841120807,
"capexToRevenueTTM": 0.255264380097805,
"salesGeneralAndAdministrativeToRevenueTTM": 0.19682725669411805,
"researchAndDevelopementToRevenueTTM": 0.1764011280055611,
"stockBasedCompensationToRevenueTTM": 0,
"intangiblesToTotalAssetsTTM": 0.20515815854009053,
"averageReceivablesTTM": 104390000000,
"averagePayablesTTM": 144422500000,
"averageInventoryTTM": 51352000000,
"daysOfSalesOutstandingTTM": 120.22815096332768,
"daysOfPayablesOutstandingTTM": 886.2600784313724,
"daysOfInventoryOutstandingTTM": 294.01537254901956,
"operatingCycleTTM": 414.2435235123472,
"cashConversionCycleTTM": -472.0165549190252,
"freeCashFlowToEquityTTM": 113405000000,
"freeCashFlowToFirmTTM": 78246685907.13214,
"tangibleAssetValueTTM": 99220000000,
"netCurrentAssetValueTTM": -164968000000,
"grossProfitMarginTTM": 0.8064845142078311,
"ebitMarginTTM": 0.45649923656243646,
"ebitdaMarginTTM": 0.5252207594306547,
"operatingProfitMarginTTM": 0.43134070564093846,
"pretaxProfitMarginTTM": 0.45153309797802876,
"continuousOperationsProfitMarginTTM": 0.35346703862113765,
"netProfitMarginTTM": 0.35346703862113765,
"bottomLineProfitMarginTTM": 0.35346703862113765,
"receivablesTurnoverTTM": 3.0358946475965793,
"payablesTurnoverTTM": 0.4118429893017727,
"inventoryTurnoverTTM": 1.2414316871786883,
"fixedAssetTurnoverTTM": 1.4214439199509834,
"assetTurnoverTTM": 0.5537204529524776,
"quickRatioTTM": 0.6581145459944873,
"solvencyRatioTTM": 0.3722113984756359,
"cashRatioTTM": 0.186052542422506,
"priceToEarningsRatioTTM": 9.517543859649123,
"priceToEarningsGrowthRatioTTM": 1.9012245614035148,
"forwardPriceToEarningsGrowthRatioTTM": -1.5797165419644723,
"priceToEarningsDilutedRatioTTM": 9.528445971744942,
"priceToEarningsDilutedGrowthRatioTTM": 1.9172155402825541,
"priceToBookRatioTTM": 4.993840857612857,
"priceToSalesRatioTTM": 3.365260834396277,
"priceToFreeCashFlowRatioTTM": 22.663312180550726,
"priceToOperatingCashFlowRatioTTM": 8.307874831402387,
"debtToAssetsRatioTTM": 0.23553091819188793,
"debtToEquityRatioTTM": 0.6332650930733876,
"debtToCapitalRatioTTM": 0.3877295215326892,
"longTermDebtToCapitalRatioTTM": 0.35501106185017095,
"financialLeverageRatioTTM": 2.6886707610822635,
"workingCapitalTurnoverRatioTTM": -8.422329600654496,
"operatingCashFlowRatioTTM": 0.5563298101496134,
"operatingCashFlowSalesRatioTTM": 0.4037537450938133,
"freeCashFlowOperatingCashFlowRatioTTM": 0.3677721056469863,
"debtServiceCoverageRatioTTM": 7.0468225749912365,
"interestCoverageRatioTTM": 86.85635696821515,
"shortTermOperatingCashFlowCoverageRatioTTM": 7.255168275786833,
"operatingCashFlowCoverageRatioTTM": 0.9492032227907541,
"capitalExpenditureCoverageRatioTTM": 1.5817081291918376,
"dividendPaidAndCapexCoverageRatioTTM": 0.9775257777418478,
"dividendPayoutRatioTTM": 0.44635572769509546,
"dividendYieldTTM": 0.04688439,
"revenuePerShareTTM": 74.39625352778724,
"netIncomePerShareTTM": 26.296623418974317,
"interestDebtPerShareTTM": 32.014704411120086,
"cashPerShareTTM": 10.158401231781239,
"bookValuePerShareTTM": 49.971556386217976,
"tangibleBookValuePerShareTTM": 22.407108848369003,
"shareholdersEquityPerShareTTM": 49.971556386217976,
"operatingCashFlowPerShareTTM": 30.037765982792912,
"capexPerShareTTM": 18.990713538369747,
"freeCashFlowPerShareTTM": 11.047052444423166,
"netIncomePerEBTTTM": 0.7828153466577926,
"ebtPerEbitTTM": 1.0468130924650063,
"priceToFairValueTTM": 4.993840857612857,
"debtToMarketCapTTM": 0.12639754200929287,
"effectiveTaxRateTTM": 0.21718465334220735,
"enterpriseValueMultipleTTM": 6.960110978453856,
"dividendPerShareTTM": 11.7,
"revenue_history": [
{
"date": "2025",
"revenue": 309064000000
}
],
"dcf": {
"symbol": "NVO",
"date": "2026-10-07",
"dcf": 74.36932827870174,
"Stock Price": 37.53
},
"statements": {
"income": [
{
"date": "2025-12-31",
"symbol": "NVO",
"reportedCurrency": "DKK",
"cik": "0000353278",
"filingDate": "2026-02-04",
"acceptedDate": "2026-02-04 09:23:00",
"fiscalYear": "2025",
"period": "FY",
"revenue": 309064000000,
"costOfRevenue": 58788000000,
"grossProfit": 250276000000,
"researchAndDevelopmentExpenses": 52039000000,
"generalAndAdministrativeExpenses": 5969000000,
"sellingAndMarketingExpenses": 64310000000,
"sellingGeneralAndAdministrativeExpenses": 70279000000,
"otherExpenses": 300000000,
"operatingExpenses": 122618000000,
"costAndExpenses": 181406000000,
"netInterestIncome": -2938000000,
"interestIncome": 1269000000,
"interestExpense": 4207000000,
"depreciationAndAmortization": 21982000000,
"ebitda": 156729000000,
"ebit": 134747000000,
"nonOperatingIncomeExcludingInterest": -7089000000,
"operatingIncome": 127658000000,
"totalOtherIncomeExpensesNet": 2882000000,
"incomeBeforeTax": 130540000000,
"incomeTaxExpense": 28106000000,
"netIncomeFromContinuingOperations": 102434000000,
"netIncomeFromDiscontinuedOperations": 0,
"otherAdjustmentsToNetIncome": 0,
"netIncome": 102434000000,
"netIncomeDeductions": 0,
"bottomLineNetIncome": 102434000000,
"eps": 23.06,
"epsDiluted": 23.03,
"weightedAverageShsOut": 4447851000,
"weightedAverageShsOutDil": 4447851000
}
],
"balance_sheet": [
{
"date": "2025-12-31",
"symbol": "NVO",
"reportedCurrency": "DKK",
"cik": "0000353278",
"filingDate": "2026-02-04",
"acceptedDate": "2026-02-04 09:23:00",
"fiscalYear": "2025",
"period": "FY",
"cashAndCashEquivalents": 26464000000,
"shortTermInvestments": 498000000,
"cashAndShortTermInvestments": 26962000000,
"netReceivables": 75697453000,
"accountsReceivables": 70856000000,
"otherReceivables": 4847581000,
"inventory": 49623000000,
"prepaids": 0,
"otherCurrentAssets": 20170547000,
"totalCurrentAssets": 172453000000,
"propertyPlantEquipmentNet": 208378000000,
"goodwill": 19845000000,
"intangibleAssets": 110208000000,
"goodwillAndIntangibleAssets": 130053000000,
"longTermInvestments": 2507000000,
"taxAssets": 23647000000,
"otherNonCurrentAssets": 5864000000,
"totalNonCurrentAssets": 370449000000,
"otherAssets": 0,
"totalAssets": 542902000000,
"totalPayables": 28171563000,
"accountPayables": 19758000000,
"otherPayables": 8416000000,
"accruedExpenses": 0,
"shortTermDebt": 12017000000,
"capitalLeaseObligationsCurrent": 0,
"taxPayables": 0,
"deferredRevenue": 0,
"otherCurrentLiabilities": 175472437000,
"totalCurrentLiabilities": 215661000000,
"longTermDebt": 110369000000,
"capitalLeaseObligationsNonCurrent": 8572000000,
"deferredRevenueNonCurrent": 0,
"deferredTaxLiabilitiesNonCurrent": 6610428000,
"otherNonCurrentLiabilities": 7641339000,
"totalNonCurrentLiabilities": 133194000000,
"otherLiabilities": 0,
"capitalLeaseObligations": 8572000000,
"totalLiabilities": 348855000000,
"treasuryStock": -2000000,
"preferredStock": 0,
"commonStock": 446000000,
"retainedEarnings": 195298000000,
"additionalPaidInCapital": 0,
"accumulatedOtherComprehensiveIncomeLoss": -1695000000,
"otherTotalStockholdersEquity": 0,
"totalStockholdersEquity": 194047000000,
"totalEquity": 194047000000,
"minorityInterest": 0,
"totalLiabilitiesAndTotalEquity": 542902000000,
"totalInvestments": 3005000000,
"totalDebt": 130958000000,
"netDebt": 104494000000
}
],
"cash_flow": [
{
"date": "2025-12-31",
"symbol": "NVO",
"reportedCurrency": "DKK",
"cik": "0000353278",
"filingDate": "2026-02-04",
"acceptedDate": "2026-02-04 09:23:00",
"fiscalYear": "2025",
"period": "FY",
"netIncome": 102434000000,
"depreciationAndAmortization": 21982000000,
"deferredIncomeTax": 28106000000,
"stockBasedCompensation": 0,
"changeInWorkingCapital": 3737000000,
"accountsReceivables": 0,
"inventory": 0,
"accountsPayables": 0,
"otherWorkingCapital": 3737000000,
"otherNonCashItems": -37157000000,
"netCashProvidedByOperatingActivities": 119102000000,
"investmentsInPropertyPlantAndEquipment": -60140000000,
"acquisitionsNet": 1004000000,
"purchasesOfInvestments": -723000000,
"salesMaturitiesOfInvestments": 10674000000,
"otherInvestingActivities": -29973000000,
"netCashProvidedByInvestingActivities": -79158000000,
"netDebtIssuance": 24743000000,
"longTermNetDebtIssuance": 24743000000,
"shortTermNetDebtIssuance": 0,
"netStockIssuance": -1388000000,
"netCommonStockIssuance": -1388000000,
"commonStockIssuance": 0,
"commonStockRepurchased": -1388000000,
"netPreferredStockIssuance": 0,
"netDividendsPaid": -51763000000,
"commonDividendsPaid": -51763000000,
"preferredDividendsPaid": 0,
"otherFinancingActivities": 0,
"netCashProvidedByFinancingActivities": -28408000000,
"effectOfForexChangesOnCash": -727000000,
"netChangeInCash": 10809000000,
"cashAtEndOfPeriod": 26464000000,
"cashAtBeginningOfPeriod": 15655000000,
"operatingCashFlow": 119102000000,
"capitalExpenditure": -90113000000,
"freeCashFlow": 28989000000,
"incomeTaxesPaid": 0,
"interestPaid": 0
}
]
}
}
Data:
{
"price": 37.53,
"rsi": 28.639487830811817,
"sma20": 40.263499999999915,
"sma50": 44.21220000000033,
"sma200": 45.54265000000005,
"adx": 36.045558918645646,
"atr": 1.01,
"atr_pct": 2.69,
"atr_expansion_pct": -25.9,
"di_plus": 9.3,
"di_minus": 44.2,
"high_52w": 63.98,
"low_52w": 35.29,
"structure": {
"ema8": 38.079330181704755,
"ema21": 40.19344991246731,
"ema50": 42.86440194067629,
"ema200": 47.24037577007149,
"ema10": 38.401257635822496,
"ema20": 40.04656944865259,
"ema10_slope_pct": -3.81,
"ema20_slope_pct": -3.92,
"trend_dir": "down",
"checks": {
"price_above_all": false,
"ema_stacked": false,
"ema21_rising": false,
"ema50_rising": false,
"adx_over_30": true,
"higher_highs_lows": false,
"lower_highs_lows": true,
"near_21ema": false
},
"dist_21ema_pct": -6.6,
"_no_bars": false,
"macd": {
"macd": -2.126,
"signal": -2.017,
"histogram": -0.108
},
"bollinger": {
"mid": 40.26,
"upper": 45.34,
"lower": 35.19,
"width_pct": 25.22
},
"crossover": {
"fresh_cross": null,
"pre_compressed": null,
"held_above_21": null,
"candles_since": null,
"intraday_support": false
},
"momentum": {
"roc10": -4.7,
"ret_3d": 0.35,
"ret_5d": -2.04,
"roc10_accel": 5.18,
"checks": {
"roc_over_5": false,
"rsi_in_band": false,
"macd_expanding": false,
"top_quartile_3d": false,
"no_big_down": true,
"near_high": false
},
"volume": {
"rvol": 0.92,
"checks": {
"rvol_over_2": false,
"up_vol_beats_down": false,
"obv_new_high": false,
"surge_day": true,
"pullback_declining_vol": false,
"last_up_beats_down": true
}
}
},
"relative_strength": {
"sector": "Healthcare",
"sector_etf": "XLV",
"sector_etf_ret10d": -1.44,
"checks": {
"beats_spy_all": false,
"beats_sector_10d": false,
"rs_line_at_high": false,
"sector_top3": true
}
},
"commodity": {},
"universe": {
"checks": {
"price_over_20": true,
"mcap_2b_to_200b": true,
"dollar_vol_over_10m": true,
"common_stock": true,
"no_earnings_7d": true
},
"avg_dollar_vol": 466042575.76
},
"options": {
"checks": {
"call_vol_2x": false,
"ivr_under_40": true,
"iv_contracting": false,
"oi_calls_above_price": false
},
"vals": {
"call_vol_mult": 0.7,
"iv_rank": 31.0
}
}
}
}
Data:
{
"prior_day": {
"high": 37.53,
"low": 36.84,
"close": 37.53,
"date": "2026-10-06"
},
"woodie_pivots": {
"PP": 37.36,
"R1": 37.87,
"S1": 37.19,
"R2": 38.04,
"S2": 36.67
},
"swing": {
"high_20d": 45.4,
"low_20d": 36.84,
"high_60d": 52.12,
"low_60d": 36.84
},
"orb": {
"high": 37.43,
"low": 37.2,
"date": "2026-10-06"
},
"vwap": 37.23,
"volume_profile": {
"poc": 39.82,
"vah": 39.88,
"val": 37.02,
"sessions": 20
},
"intraday": {
"h1_trend": "flat",
"h1_last": 37.2,
"h1_ema9": 37.19,
"h1_ema21": 37.3,
"m15_trend": "up",
"m15_last": 37.48,
"m15_ema9": 37.27,
"m15_ema21": 37.21,
"rvol_intraday": 0.89,
"as_of_et": "2026-10-06 15:55"
},
"premarket": {
"date": "2026-10-07",
"high": 37.54,
"low": 37.08,
"last": 37.49,
"volume": 80058,
"gap_pct": -0.11,
"path": "04:00 37.18 -> 04:55 37.44 -> 05:50 37.40 -> 06:40 37.40 -> 07:25 37.48 -> 07:30 37.49",
"bars": 38,
"last_bar_et": "07:30"
},
"recent_daily": [
{
"d": "2026-09-01",
"o": 45.8,
"h": 46.16,
"l": 45.065,
"c": 45.12,
"v": 9355998.435992
},
{
"d": "2026-09-02",
"o": 46.05,
"h": 47.005,
"l": 45.91,
"c": 46.77,
"v": 13602634.976415
},
{
"d": "2026-09-03",
"o": 47.99,
"h": 48,
"l": 46.565,
"c": 47.51,
"v": 8769639.17081
},
{
"d": "2026-09-04",
"o": 46.35,
"h": 46.74,
"l": 46.0417,
"c": 46.6,
"v": 6219243.654148
},
{
"d": "2026-09-08",
"o": 45.58,
"h": 45.91,
"l": 45.145,
"c": 45.16,
"v": 10353971.020859
},
{
"d": "2026-09-09",
"o": 45,
"h": 45.395,
"l": 44.52,
"c": 44.56,
"v": 8833554.15123
},
{
"d": "2026-09-10",
"o": 44.6,
"h": 44.82,
"l": 44.01,
"c": 44.01,
"v": 6580888.654266
},
{
"d": "2026-09-11",
"o": 43.195,
"h": 43.4951,
"l": 42.7216,
"c": 43.07,
"v": 11029063.248993
},
{
"d": "2026-09-14",
"o": 43.66,
"h": 43.71,
"l": 43.0701,
"c": 43.45,
"v": 6564589.024442
},
{
"d": "2026-09-15",
"o": 42.725,
"h": 43,
"l": 42.4,
"c": 42.53,
"v": 8862135.968816
},
{
"d": "2026-09-16",
"o": 42.47,
"h": 42.72,
"l": 41.47,
"c": 41.71,
"v": 11669847.379135
},
{
"d": "2026-09-17",
"o": 41.98,
"h": 43.44,
"l": 41.96,
"c": 43.19,
"v": 12947146.586894
},
{
"d": "2026-09-18",
"o": 43.5,
"h": 43.54,
"l": 42.78,
"c": 43.24,
"v": 10370709.419651
},
{
"d": "2026-09-21",
"o": 41.05,
"h": 41.17,
"l": 39.54,
"c": 39.8,
"v": 49339314.753733
},
{
"d": "2026-09-22",
"o": 39.5,
"h": 39.89,
"l": 39.105,
"c": 39.4,
"v": 24462879.194482
},
{
"d": "2026-09-23",
"o": 38.9,
"h": 39.14,
"l": 38.16,
"c": 38.17,
"v": 18439042.70454
},
{
"d": "2026-09-24",
"o": 37.95,
"h": 38.7197,
"l": 37.92,
"c": 38.62,
"v": 20064204.307896
},
{
"d": "2026-09-25",
"o": 38.81,
"h": 38.83,
"l": 38.41,
"c": 38.8,
"v": 10061950.69129
},
{
"d": "2026-09-28",
"o": 38.4,
"h": 38.8984,
"l": 38.2323,
"c": 38.71,
"v": 11428804.504097
},
{
"d": "2026-09-29",
"o": 38.21,
"h": 38.38,
"l": 38.05,
"c": 38.31,
"v": 9403505.705784
},
{
"d": "2026-09-30",
"o": 38.05,
"h": 38.77,
"l": 37.885,
"c": 37.91,
"v": 21556020.882594
},
{
"d": "2026-10-01",
"o": 37.8,
"h": 37.97,
"l": 37.365,
"c": 37.4,
"v": 12656899.537146
},
{
"d": "2026-10-02",
"o": 37.635,
"h": 37.65,
"l": 37.17,
"c": 37.32,
"v": 10261230.528137
},
{
"d": "2026-10-05",
"o": 36.94,
"h": 37.61,
"l": 36.855,
"c": 37.54,
"v": 18700717.659643
},
{
"d": "2026-10-06",
"o": 37.35,
"h": 37.53,
"l": 36.845,
"c": 37.53,
"v": 13696527.755831
}
]
}
Data:
{
"sector": "Healthcare",
"etf": "XLV",
"etf_trend": "mixed",
"etf_r5d": -2.13,
"etf_rvol": 0.9,
"rs_5d": -0.89,
"leading": false
}
Data:
{
"estimates": [
{
"symbol": "NVO",
"date": "2030-12-31",
"revenueLow": 343187340997,
"revenueHigh": 409116275198,
"revenueAvg": 367650179331,
"ebitdaLow": 190457840485,
"ebitdaHigh": 227687422709,
"ebitdaAvg": 204271839282,
"ebitLow": 148015012777,
"ebitHigh": 185244595001,
"ebitAvg": 161829011574,
"netIncomeLow": 116430417125,
"netIncomeHigh": 146143173775,
"netIncomeAvg": 127455305402,
"sgaExpenseLow": 89410267885,
"sgaExpenseHigh": 106586669704,
"sgaExpenseAvg": 95783547629,
"epsAvg": 28.65548,
"epsHigh": 32.85703,
"epsLow": 26.17678,
"numAnalystsRevenue": 14,
"numAnalystsEps": 4
},
{
"symbol": "NVO",
"date": "2029-12-31",
"revenueLow": 329656936845,
"revenueHigh": 392986576087,
"revenueAvg": 353155310439,
"ebitdaLow": 178971232683,
"ebitdaHigh": 214181018464,
"ebitdaAvg": 192035763389,
"ebitLow": 140100511582,
"ebitHigh": 175310297363,
"ebitAvg": 153165042288,
"netIncomeLow": 110113890483,
"netIncomeHigh": 138214656973,
"netIncomeAvg": 120540631757,
"sgaExpenseLow": 85885204704,
"sgaExpenseHigh": 102384414708,
"sgaExpenseAvg": 92007213377,
"epsAvg": 27.10087,
"epsHigh": 31.07448,
"epsLow": 24.75665,
"numAnalystsRevenue": 14,
"numAnalystsEps": 2
},
{
"symbol": "NVO",
"date": "2028-12-31",
"revenueLow": 305514345402,
"revenueHigh": 364206006688,
"revenueAvg": 327291803797,
"ebitdaLow": 159615847140,
"ebitdaHigh": 190882955934,
"ebitdaAvg": 171217443774,
"ebitLow": 124651091821,
"ebitHigh": 155918200615,
"ebitAvg": 136252688455,
"netIncomeLow": 97783780331,
"netIncomeHigh": 122737914630,
"netIncomeAvg": 107042960717,
"sgaExpenseLow": 79595358575,
"sgaExpenseHigh": 94886240642,
"sgaExpenseAvg": 85269018866,
"epsAvg": 24.06622,
"epsHigh": 27.59488,
"epsLow": 21.9845,
"numAnalystsRevenue": 13,
"numAnalystsEps": 4
},
{
"symbol": "NVO",
"date": "2027-12-31",
"revenueLow": 304702364232,
"revenueHigh": 313594965420,
"revenueAvg": 308364023545,
"ebitdaLow": 147463624260,
"ebitdaHigh": 163372433184,
"ebitdaAvg": 156502717706,
"ebitLow": 116383591603,
"ebitHigh": 132292400527,
"ebitAvg": 125422685049,
"netIncomeLow": 91185526807,
"netIncomeHigh": 103882273317,
"netIncomeAvg": 98399585302,
"sgaExpenseLow": 79383813902,
"sgaExpenseHigh": 81700594737,
"sgaExpenseAvg": 80337782481,
"epsAvg": 22.12295,
"epsHigh": 23.35561,
"epsLow": 20.50103,
"numAnalystsRevenue": 16,
"numAnalystsEps": 7
}
],
"price_target": {
"symbol": "NVO",
"targetHigh": 47,
"targetLow": 40,
"targetConsensus": 44.67,
"targetMedian": 47
},
"ratings": {
"symbol": "NVO",
"rating": "A-",
"overallScore": 4,
"discountedCashFlowScore": 5,
"returnOnEquityScore": 5,
"returnOnAssetsScore": 5,
"debtToEquityScore": 1,
"priceToEarningsScore": 3,
"priceToBookScore": 1
},
"grades": [
{
"symbol": "NVO",
"date": "2026-09-11",
"gradingCompany": "Morgan Stanley",
"previousGrade": "Equal Weight",
"newGrade": "Underweight",
"action": "downgrade"
},
{
"symbol": "NVO",
"date": "2026-03-02",
"gradingCompany": "Goldman Sachs",
"previousGrade": "Buy",
"newGrade": "Neutral",
"action": "downgrade"
},
{
"symbol": "NVO",
"date": "2026-02-24",
"gradingCompany": "JP Morgan",
"previousGrade": "Overweight",
"newGrade": "Neutral",
"action": "downgrade"
},
{
"symbol": "NVO",
"date": "2025-12-08",
"gradingCompany": "Argus Research",
"previousGrade": "Buy",
"newGrade": "Hold",
"action": "downgrade"
},
{
"symbol": "NVO",
"date": "2025-11-28",
"gradingCompany": "Goldman Sachs",
"previousGrade": "Buy",
"newGrade": "Buy",
"action": "maintain"
},
{
"symbol": "NVO",
"date": "2025-11-25",
"gradingCompany": "BMO Capital",
"previousGrade": "Market Perform",
"newGrade": "Market Perform",
"action": "maintain"
},
{
"symbol": "NVO",
"date": "2025-11-24",
"gradingCompany": "HSBC",
"previousGrade": "Buy",
"newGrade": "Hold",
"action": "downgrade"
},
{
"symbol": "NVO",
"date": "2025-10-14",
"gradingCompany": "BMO Capital",
"previousGrade": "Market Perform",
"newGrade": "Market Perform",
"action": "maintain"
}
]
}
Data:
[
{
"title": "AGIO Stock Sinks 29% in Three Months: Here's What You Need to Know",
"url": "https://www.zacks.com/stock/news/3001176/agio-stock-sinks-29-in-three-months-here-s-what-you-need-to-know?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-3001176",
"source": "Zacks Investment Research",
"date": "2026-10-06T13:55:00Z",
"summary": "Agios Pharmaceuticals' stock declined 29% over three months following the discontinuation of tebapivat across all indications after failing to demonstrate differentiation from existing treatments. With tebapivat no longer advancing, the company is increasingly dependent on mitapi",
"image": "https://staticx-tuner.zacks.com/images/articles/main/08/595.jpg"
},
{
"title": "Eli Lilly and vs. Novo Nordisk A/S: Which Healthcare Stock Is a Better Buy in 2026?",
"url": "https://www.fool.com/coverage/better-buy/2026/10/06/eli-lilly-and-vs-novo-nordisk-as-which-healthcare-stock-is-a-better-buy-in-2026/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-10-06T13:10:01Z",
"summary": "Eli Lilly and Novo Nordisk compete in the booming GLP-1 weight-loss and diabetes treatment market. Eli Lilly demonstrates superior growth with 44.7% revenue increase and 49.7% operating margins, while Novo Nordisk offers better valuation (3x lower P/E ratio) and higher dividend y",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F3a7b7d740be428c35a4ad30f93004a7d655cc124-1200x800.png%3Fw%3D800%26q%3D75%26fit%3Dmax%26auto%3Dformat&w=1200&op=resize"
},
{
"title": "Is Most-Watched Stock Novo Nordisk A/S (NVO) Worth Betting on Now?",
"url": "https://www.zacks.com/stock/news/3000789/is-most-watched-stock-novo-nordisk-a-s-nvo-worth-betting-on-now?cid=CS-ZC-FT-fundamental_analysis|most_searched_stocks-3000789",
"source": "Zacks Investment Research",
"date": "2026-10-06T12:00:04Z",
"summary": "Novo Nordisk (NVO) has declined 19.4% over the past month, underperforming the S&P 500. The pharmaceutical company is expected to report lower earnings with a -21.6% year-over-year change for the current quarter, though consensus estimates have improved slightly. Despite recent r",
"image": "https://staticx-tuner.zacks.com/images/default_article_images/default226.jpg"
},
{
"title": "Novo Stock Is Down More Than 70% From Its Peak. Value Trap or Generational Buying Opportunity?",
"url": "https://www.fool.com/investing/2026/10/06/novo-stock-is-down-more-than-70-from-its-peak-valu/",
"source": "The Motley Fool",
"date": "2026-10-06 20:15:00",
"summary": "Novo Nordisk rose dramatically because investors were excited after it launched the first GLP-1 weight-loss drug. The company lost the lead in the emerging GLP-1 space to Eli Lilly.",
"image": "https://images.financialmodelingprep.com/news/novo-stock-is-down-more-than-70-from-its-20261006.jpg"
},
{
"title": "Novo Nordisk A/S $NVO Stock Sold by Eastern Bank",
"url": "https://www.defenseworld.net/2026/10/06/novo-nordisk-a-s-nvo-stock-sold-by-eastern-bank.html",
"source": "Defense World",
"date": "2026-10-06 03:15:26",
"summary": "Eastern Bank decreased its stake in Novo Nordisk A/S (NYSE: NVO) by 32.8% during the undefined quarter, according to the company in its most recent disclosure with the SEC. The firm owned 82,419 shares of the company's stock after selling 40,164 shares during the period. Eastern ",
"image": "https://images.financialmodelingprep.com/news/novo-nordisk-as-nvo-stock-sold-by-eastern-bank-20261006.jpg"
},
{
"title": "Type 2 Diabetes Market to Grow Significantly During the Forecast Period (2026\u20132036), with Rising Prevalence and Increasing Uptake of Next-Generation Therapies | DelveInsight",
"url": "https://www.globenewswire.com/news-release/2026/10/05/3374910/0/en/type-2-diabetes-market-to-grow-significantly-during-the-forecast-period-2026-2036-with-rising-prevalence-and-increasing-uptake-of-next-generation-therapies-delveinsight.html",
"source": "GlobeNewswire Inc.",
"date": "2026-10-05T17:00:00Z",
"summary": "The type 2 diabetes market is projected to experience steady growth through 2036, driven by rising global prevalence, obesity, and adoption of next-generation therapies including GLP-1 receptor agonists and SGLT2 inhibitors. Key emerging drugs from major pharmaceutical companies ",
"image": "https://ml.globenewswire.com/Resource/Download/dbcddd65-71dd-4559-8875-ae89ac4f96db"
},
{
"title": "Here Are My Top 4 Stocks to Buy in October",
"url": "https://www.fool.com/investing/2026/10/05/here-are-my-top-4-stocks-to-buy-in-october/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-10-05T12:24:00Z",
"summary": "The article recommends four stocks for October investment: Viking Therapeutics for its unique monthly-dose GLP-1 weight loss drug candidate in a market expected to reach $200 billion by 2030; Alphabet for its dominant position in cloud computing AI services with 82% YoY growth an",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F889228%2Fyoung-investor-sitting-at-desk.jpg&w=1200&op=resize"
},
{
"title": "Novo's Denecimig BLA Review Delayed by FDA Facility Remediation Work",
"url": "https://www.zacks.com/stock/news/3000274/novo-s-denecimig-bla-review-delayed-by-fda-facility-remediation-work?cid=CS-STOCKNEWSAPI-FT-analyst_blog|company_news_medical_sector-3000274",
"source": "Zacks Investment Research",
"date": "2026-10-05 12:41:16",
"summary": "NVO's denecimig FDA review is delayed by manufacturing facility remediation, while no clinical efficacy or safety deficiencies were identified.",
"image": "https://images.financialmodelingprep.com/news/novos-denecimig-bla-review-delayed-by-fda-facility-remediation-20261005.jpg"
},
{
"title": "Better High-Yield Dividend Stock: Pfizer or Novo Nordisk?",
"url": "https://www.fool.com/investing/2026/10/04/better-high-yield-dividend-stock-pfizer-or-novo-no/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-10-04T21:15:00Z",
"summary": "Both Pfizer and Novo Nordisk face significant dividend safety concerns despite high yields. Novo Nordisk (4.7% yield) leads in GLP-1 drugs but has lost market share to Eli Lilly and lacks portfolio diversity, while Pfizer (6% yield) faces patent expirations and R&D challenges. Ho",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F889223%2F26_10_01-a-wooden-spoon-with-pills-in-it-and-a-money-roll-in-the-background-_mf-dload-gettyimages-2247766275-1280x853-c533c3e.jpg&w=1200&op=resize"
},
{
"title": "Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP",
"url": "https://www.fool.com/coverage/etfs/2026/10/02/better-pharmaceuticals-etf-vaneck-s-pph-vs-invesco-pjp/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-10-03T00:13:28Z",
"summary": "VanEck Pharmaceutical ETF (PPH) offers lower costs (0.36% expense ratio) and higher dividend yield (2%), making it better for long-term buy-and-hold investors. Invesco Pharmaceuticals ETF (PJP) delivered stronger 1-year returns (41% vs 31%) with more balanced U.S.-focused holding",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F7669db1dbfa6e097df450be5b22faf5d854bd54d-1401x1251.png%3Fw%3D800%26q%3D75%26fit%3Dmax%26auto%3Dformat&w=1200&op=resize"
},
{
"title": "Novo provides update on the denecimig Biologics License Application (BLA) in the US",
"url": "https://www.globenewswire.com/news-release/2026/10/02/3374048/0/en/novo-provides-update-on-the-denecimig-biologics-license-application-bla-in-the-us.html",
"source": "GlobeNewswire Inc.",
"date": "2026-10-02T20:53:00Z",
"summary": "The FDA has extended its review of Novo Nordisk's denecimig BLA for haemophilia A treatment due to ongoing manufacturing facility remediation activities. No deficiencies were identified in clinical efficacy or safety data. Novo aims to launch denecimig in the US in H1 2027, pendi",
"image": "https://ml-eu.globenewswire.com/Resource/Download/f87e6f85-3e50-4571-b9e5-8f683431f855"
},
{
"title": "Novo Nordisk vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?",
"url": "https://www.fool.com/coverage/better-buy/2026/10/02/novo-nordisk-vs-pfizer-which-healthcare-stock-is-a-better-buy-in-2026/?source=iedfolrf0000001",
"source": "The Motley Fool",
"date": "2026-10-02T16:15:01Z",
"summary": "Novo Nordisk and Pfizer are compared as pharmaceutical giants navigating different challenges. Novo Nordisk boasts superior profitability with a 33% net margin and strong cash flow, but faces pricing pressures and competition in the GLP-1 weight-loss drug market. Pfizer trades at",
"image": "https://g.foolcdn.com/image/?url=https%3A%2F%2Fcdn.content.foolcdn.com%2Fimages%2F1umn9qeh%2Fproduction%2F2d10dfb318519977a677bcb00f3da6d28e64e4b0-1200x800.png%3Fw%3D800%26q%3D75%26fit%3Dmax%26auto%3Dformat&w=1200&op=resize"
},
{
"title": "DXCM Report Highlights CGM Growth Opportunity in Type 2 Diabetes Care",
"url": "https://www.zacks.com/stock/news/2999558/dxcm-report-highlights-cgm-growth-opportunity-in-type-2-diabetes-care?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2999558",
"source": "Zacks Investment Research",
"date": "2026-10-02T14:00:00Z",
"summary": "Dexcom released its 2026 State of Type 2 Report highlighting significant gaps in CGM awareness and reimbursement access, with 55% of Type 2 diabetes patients having limited knowledge of the technology. However, the report reveals substantial growth opportunities as 58% of Type 2 ",
"image": "https://staticx-tuner.zacks.com/images/articles/main/d8/68148.jpg"
},
{
"title": "Agios' Growth Story Hinges on Mitapivat's Commercial Expansion",
"url": "https://www.zacks.com/stock/news/2999542/agios-growth-story-hinges-on-mitapivat-s-commercial-expansion?cid=CS-ZC-FT-analyst_blog|quick_take-2999542",
"source": "Zacks Investment Research",
"date": "2026-10-02T13:22:00Z",
"summary": "Agios Pharmaceuticals' mitapivat-based drugs (Pyrukynd and Aqvesme) generated $44.7 million in Q2 2026 revenue, up 259% year-over-year, driven by early thalassemia adoption. However, the discontinuation of pipeline drug tebapivat and intensifying competition from Novo Nordisk's e",
"image": "https://staticx-tuner.zacks.com/images/articles/main/21/594.jpg"
},
{
"title": "Big Pharma turns to China for new drugs as patent cliff drives multibillion-dollar deals",
"url": "https://www.cnbc.com/2026/10/02/novartis-abogen-china-biotech-deal.html",
"source": "CNBC",
"date": "2026-10-02T11:13:23Z",
"summary": "* Swiss Novartis is entering a licensing agreement with a Chinese biotech worth as much as $7.8 billion.\n\n* It comes after several pharma peers announced deals with China-based drug developers over the past two weeks.\n\n* ING estimates that China will account for about a third of ",
"image": "https://image.cnbcfm.com/api/v1/image/108328514-1782803221665-gettyimages-2152722520-dsc00854.jpeg?v=1782803282&w=1920&h=1080"
},
{
"title": "US FDA extends review of Novo Nordisk's hemophilia drug over facility issues",
"url": "https://www.reuters.com/legal/litigation/us-fda-extends-review-novo-nordisks-hemophilia-drug-over-facility-issues-2026-10-02/",
"source": "Reuters",
"date": "2026-10-02 17:52:21",
"summary": "The US FDA has extended its review of Novo Nordisk's experimental hemophilia A drug due \u200bto ongoing remediation work at a manufacturing facility, \u200cthe Danish drugmaker said on Friday.",
"image": "https://images.financialmodelingprep.com/news/us-fda-extends-review-of-novo-nordisks-hemophilia-drug-20261002.jpg"
},
{
"title": "Novo Nordisk Strikes Nearly $4 Billion in 2 Deals. Here's What That Means for Investors",
"url": "https://www.fool.com/investing/2026/10/02/novo-nordisk-strikes-nearly-usd4-billion-in-2-deals-here-s-what-that-means-for-investors/",
"source": "The Motley Fool",
"date": "2026-10-02 16:01:01",
"summary": "Novo has improved its pipeline through licensing deals. The recent agreements it has signed could yield powerful, differentiated weight-loss options.",
"image": "https://images.financialmodelingprep.com/news/novo-nordisk-strikes-nearly-4-billion-in-2-deals-20261002.jpg"
},
{
"title": "Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s",
"url": "https://www.cnbc.com/2026/10/02/lilly-novo-amylin-obesity-drugs.html",
"source": "CNBC",
"date": "2026-10-02 11:13:43",
"summary": "Eli Lilly and Novo are developing new amylin drugs that serve as another biological lever to pull in treating obesity and diabetes, either as independent treatments or layered on top of existing drugs.\u00a0 A new slate of injections, pills, and combination regimens target the amylin ",
"image": "https://images.financialmodelingprep.com/news/why-lilly-and-novo-are-betting-on-amylin-to-20261002.jpg"
},
{
"title": "LLY Highlights New Efficacy Data From Foundayo and EloraTZP Studies",
"url": "https://www.zacks.com/stock/news/2999377/lly-highlights-new-efficacy-data-from-foundayo-and-eloratzp-studies?cid=CS-STOCKNEWSAPI-FT-analyst_blog|company_news_medical_sector-2999377",
"source": "Zacks Investment Research",
"date": "2026-10-02 10:16:09",
"summary": "Eli Lilly's new data show Foundayo's cardiovascular safety and metabolic benefits, while EloraTZP delivers greater weight loss and A1C reduction in a mid-stage study.",
"image": "https://images.financialmodelingprep.com/news/lly-highlights-new-efficacy-data-from-foundayo-and-eloratzp-20261002.jpg"
},
{
"title": "Eli Lilly obesity drug data adds pressure on Novo Nordisk",
"url": "https://www.proactiveinvestors.com/companies/news/1099453",
"source": "Proactive Investors",
"date": "2026-10-02 02:44:04",
"summary": "Novo Nordisk (NYSE:NVO) faces further pressure in the obesity-drug market after Eli Lilly and Co (NYSE:LLY) reported promising mid-stage data for an experimental treatment that delivered greater weight loss than tirzepatide alone. EloraTZP, a combination of eloralintide and tirze",
"image": "https://images.financialmodelingprep.com/news/eli-lilly-obesity-drug-data-adds-pressure-on-novo-20261002.jpg"
},
{
"title": "There's one pharma-linked stock most investors have never heard of. It's on Josh Brown's list",
"url": "https://www.cnbc.com/2026/10/01/one-pharma-name-most-investors-have-never-heard-of-is-on-josh-browns-list.html",
"source": "CNBC",
"date": "2026-10-01T15:47:37Z",
"summary": "(This is The Best Stocks in the Market , brought to you by Josh Brown and Sean Russo of Ritholtz Wealth Management.) Josh -- There's a good chance you've never heard of West Pharmaceutical Services (WST) . There's an even better chance you've used something it makes. If you've ev",
"image": "https://image.cnbcfm.com/api/v1/image/108349296-1786729454547-108349296-1786642498604-IMG_0066.jpg?v=1786729469&w=1920&h=1080"
},
{
"title": "Novo's Wegovy Pill Shows Weight Loss After Switching From Injections",
"url": "https://www.zacks.com/stock/news/2998966/novo-s-wegovy-pill-shows-weight-loss-after-switching-from-injections?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2998966",
"source": "Zacks Investment Research",
"date": "2026-10-01T13:42:00Z",
"summary": "Novo Nordisk's oral Wegovy demonstrated an average 4.1% weight loss after three months in the OCTANE study among patients switching from injectable GLP-1 therapies, with 40.7% achieving at least 5% weight loss. Additionally, CagriSema showed benefits beyond weight reduction, incl",
"image": "https://staticx-tuner.zacks.com/images/articles/main/de/2471.jpg"
},
{
"title": "Lilly vs. Novo: Inside the Milan EASD Showdown and the ETFs Poised to Win",
"url": "https://www.zacks.com/stock/news/2998889/lilly-vs-novo-inside-the-milan-easd-showdown-and-the-etfs-poised-to-win?cid=CS-ZC-FT-etf_news_and_commentary-2998889",
"source": "Zacks Investment Research",
"date": "2026-10-01T12:48:00Z",
"summary": "At the 2026 EASD conference in Milan, Eli Lilly and Novo Nordisk presented competing clinical data in the weight-loss drug market. Lilly's retatrutide showed 34.9% of patients lost at least 25% of body weight, while Novo countered with cardiovascular safety data for Ozempic. The ",
"image": "https://staticx-tuner.zacks.com/images/articles/main/b8/1573.jpg"
},
{
"title": "Cramer's lightning round: Buy Kinder Morgan",
"url": "https://www.cnbc.com/2026/09/30/cramers-lightning-round-buy-kinder-morgan.html",
"source": "CNBC",
"date": "2026-09-30T22:55:01Z",
"summary": "* It's that time again! \"Mad Money\" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.\n\nIn this article\n\n* NVO\n\nFollow your favorite stocksCREATE FREE ACCOUNT\n\nStock Chart IconStock chart icon\n\nMPLX LP's",
"image": "https://image.cnbcfm.com/api/v1/image/102086255-mad-money-lightning.jpg?v=1698102997&w=1920&h=1080"
},
{
"title": "NVO's Ozempic Outshines LLY's Mounjaro in Lowering Cardiovascular Risk",
"url": "https://www.zacks.com/stock/news/2998472/nvo-s-ozempic-outshines-lly-s-mounjaro-in-lowering-cardiovascular-risk?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2998472",
"source": "Zacks Investment Research",
"date": "2026-09-30T17:34:00Z",
"summary": "Novo's COMPETE SWITCH CV study found that patients who escalated their Ozempic dose to 2 mg had a 6% lower observed risk of major adverse cardiovascular events (MACE) compared to those who switched to Eli Lilly's Mounjaro. However, the study shows association rather than causatio",
"image": "https://staticx-tuner.zacks.com/images/articles/main/08/595.jpg"
}
]
Data:
[
{
"symbol": "NVO",
"date": "2026-11-04",
"epsActual": null,
"epsEstimated": 0.759,
"revenueActual": null,
"revenueEstimated": 11122210000,
"lastUpdated": "2026-10-07"
},
{
"symbol": "NVO",
"date": "2026-08-05",
"epsActual": 0.96,
"epsEstimated": 0.82,
"revenueActual": 12130320000,
"revenueEstimated": 10889020000,
"lastUpdated": "2026-10-07"
},
{
"symbol": "NVO",
"date": "2026-05-06",
"epsActual": 1.04,
"epsEstimated": 0.87,
"revenueActual": 11022700000,
"revenueEstimated": 10859740000,
"lastUpdated": "2026-08-06"
},
{
"symbol": "NVO",
"date": "2026-02-03",
"epsActual": 1,
"epsEstimated": 0.9,
"revenueActual": 12503300000,
"revenueEstimated": 12127790000,
"lastUpdated": "2026-07-07"
},
{
"symbol": "NVO",
"date": "2025-11-05",
"epsActual": 1.02,
"epsEstimated": 0.77,
"revenueActual": 11529450000,
"revenueEstimated": 11944030000,
"lastUpdated": "2026-07-07"
}
]
Data:
{
"borrow": [],
"short_interest": [
{
"symbol": "NVO",
"file_date": "",
"error": "Symbol not found in FINRA biweekly file",
"days_to_cover": null
}
],
"ftd": {
"symbol": "NVO",
"periods": [
{
"file_period": "202606b",
"settlement_date": "20260630",
"quantity_fails": 2305,
"price": 48.34
},
{
"file_period": "202607a",
"settlement_date": "20260714",
"quantity_fails": 27397,
"price": 49.28
},
{
"file_period": "202607b",
"settlement_date": "20260730",
"quantity_fails": 11943,
"price": 51.58
},
{
"file_period": "202608a",
"settlement_date": "20260810",
"quantity_fails": 5998,
"price": 47.26
},
{
"file_period": "202608b",
"settlement_date": "20260826",
"quantity_fails": 12219,
"price": 48.66
},
{
"file_period": "202609a",
"settlement_date": "20260911",
"quantity_fails": 13000,
"price": 44.01
}
],
"trend": "rising",
"trend_description": "FTD quantity increasing \u2014 settlement pressure building, potential squeeze precursor"
}
}
Data:
{
"insider": {
"status": "not_found",
"endpoint": "search-insider-trades",
"provided": "symbol=\"NVO\"",
"message": "No data returned for search-insider-trades with symbol=\"NVO\". The identifier may not exist, or may have no data for this endpoint. Use the 'search' tool to verify the symbol/cik/name."
},
"congress": [
{
"symbol": "NVO",
"senateID": "T000278",
"disclosureDate": "2024-02-14",
"transactionDate": "2024-01-19",
"firstName": "Thomas Hawley",
"lastName": "Tuberville",
"office": "Thomas H Tuberville",
"district": "AL",
"owner": "Joint",
"assetDescription": "Novo Nordisk A/S Common Stock",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/3dabcae6-b7fd-4dd0-9ece-e936d07def11/"
},
{
"symbol": "NVO",
"senateID": "C000174",
"disclosureDate": "2021-05-17",
"transactionDate": "2020-04-02",
"firstName": "Thomas Richard",
"lastName": "Carper",
"office": "Thomas R. Carper",
"district": "DE",
"owner": "Spouse",
"assetDescription": "Novo Nordisk A/S",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "--",
"link": "https://efdsearch.senate.gov/search/view/ptr/bc6505f6-4219-4ce3-b146-a9faaabda324/"
},
{
"symbol": "NVO",
"senateID": "C000174",
"disclosureDate": "2020-05-04",
"transactionDate": "2020-04-02",
"firstName": "Thomas Richard",
"lastName": "Carper",
"office": "Thomas R Carper",
"district": "DE",
"owner": "Spouse",
"assetDescription": "Novo Nordisk A/S",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/a1c431fc-093e-4ace-8f0a-4f2ae481556d/"
},
{
"symbol": "NVO",
"senateID": "C001047",
"disclosureDate": "2019-04-17",
"transactionDate": "2019-03-11",
"firstName": "Shelley Moore",
"lastName": "Capito",
"office": "Shelley M Capito",
"district": "WV",
"owner": "Spouse",
"assetDescription": "Novo Nordisk A/S",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/46cecbcc-7c1c-4cbb-aa4f-fa1d2cd63627/"
},
{
"symbol": "NVO",
"senateID": "C001047",
"disclosureDate": "2017-10-06",
"transactionDate": "2017-09-08",
"firstName": "Shelley Moore",
"lastName": "Capito",
"office": "Shelley M Capito",
"district": "WV",
"owner": "Spouse",
"assetDescription": "Novo Nordisk A/S",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://efdsearch.senate.gov/search/view/ptr/2697b867-b20d-47be-98d3-a8d19339b36d/"
},
{
"symbol": "NVO",
"senateID": "H001082",
"disclosureDate": "2026-09-28",
"transactionDate": "2026-08-31",
"firstName": "Kevin",
"lastName": "Hern",
"office": "Kevin Hern",
"district": "OK01",
"owner": "",
"assetDescription": "Novo Nordisk A/S",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20035491.pdf"
},
{
"symbol": "NVO",
"senateID": "H001082",
"disclosureDate": "2026-09-28",
"transactionDate": "2026-09-10",
"firstName": "Kevin",
"lastName": "Hern",
"office": "Kevin Hern",
"district": "OK01",
"owner": "",
"assetDescription": "Novo Nordisk A/S",
"assetType": "Stock",
"type": "Sale",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20035491.pdf"
},
{
"symbol": "NVO",
"senateID": "H001082",
"disclosureDate": "2026-09-25",
"transactionDate": "2026-08-31",
"firstName": "Kevin",
"lastName": "Hern",
"office": "Kevin Hern",
"district": "OK01",
"owner": "",
"assetDescription": "Novo Nordisk A/S Common Stock",
"assetType": "Stock",
"type": "Sale (Partial)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20035491.pdf"
},
{
"symbol": "NVO",
"senateID": "F000472",
"disclosureDate": "2026-09-18",
"transactionDate": "2026-08-26",
"firstName": "Scott Mr",
"lastName": "Franklin",
"office": "Scott Mr Franklin",
"district": "FL18",
"owner": "",
"assetDescription": "Novo Nordisk A/S",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20035450.pdf"
},
{
"symbol": "NVO",
"senateID": "F000472",
"disclosureDate": "2026-09-18",
"transactionDate": "2026-08-26",
"firstName": "Scott",
"lastName": "Franklin",
"office": "Scott Mr Franklin",
"district": "FL18",
"owner": "",
"assetDescription": "Novo Nordisk A/S",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20035450.pdf"
},
{
"symbol": "NVO",
"senateID": "M001136",
"disclosureDate": "2025-11-24",
"transactionDate": "2025-10-31",
"firstName": "Lisa C.",
"lastName": "McClain",
"office": "Lisa McClain",
"district": "MI09",
"owner": "Spouse",
"assetDescription": "Novo Nordisk A/S Common Stock",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20033446.pdf"
},
{
"symbol": "NVO",
"senateID": "M001136",
"disclosureDate": "2025-11-24",
"transactionDate": "2025-10-30",
"firstName": "Lisa C.",
"lastName": "McClain",
"office": "Lisa McClain",
"district": "MI09",
"owner": "Spouse",
"assetDescription": "Novo Nordisk A/S Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20033446.pdf"
},
{
"symbol": "NVO",
"senateID": "M001136",
"disclosureDate": "2025-11-24",
"transactionDate": "2025-10-30",
"firstName": "Lisa C.",
"lastName": "McClain",
"office": "Lisa McClain",
"district": "MI09",
"owner": "Spouse",
"assetDescription": "Novo Nordisk A/S Common Stock",
"assetType": "Stock",
"type": "Sale (Full)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20033446.pdf"
},
{
"symbol": "NVO",
"senateID": "M001136",
"disclosureDate": "2025-10-22",
"transactionDate": "2025-09-11",
"firstName": "Lisa C.",
"lastName": "McClain",
"office": "Lisa McClain",
"district": "MI09",
"owner": "Spouse",
"assetDescription": "Novo Nordisk A/S Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20032129.pdf"
},
{
"symbol": "NVO",
"senateID": "G000596",
"disclosureDate": "2025-10-21",
"transactionDate": "2025-10-15",
"firstName": "Marjorie Taylor",
"lastName": "Greene",
"office": "Marjorie Taylor Greene",
"district": "GA14",
"owner": "",
"assetDescription": "Novo Nordisk A/S Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20033314.pdf"
},
{
"symbol": "NVO",
"senateID": "M001136",
"disclosureDate": "2025-09-15",
"transactionDate": "2025-08-04",
"firstName": "Lisa C.",
"lastName": "McClain",
"office": "Lisa McClain",
"district": "MI09",
"owner": "Spouse",
"assetDescription": "Novo Nordisk A/S Common Stock",
"assetType": "Stock",
"type": "Sale (Partial)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030932.pdf"
},
{
"symbol": "NVO",
"senateID": "H001094",
"disclosureDate": "2025-09-12",
"transactionDate": "2024-10-29",
"firstName": "Val",
"lastName": "Hoyle",
"office": "Valerie Hoyle",
"district": "OR04",
"owner": "Spouse",
"assetDescription": "Novo Nordisk A/S Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20032070.pdf"
},
{
"symbol": "NVO",
"senateID": "G000596",
"disclosureDate": "2025-09-01",
"transactionDate": "2025-08-28",
"firstName": "Marjorie Taylor",
"lastName": "Greene",
"office": "Marjorie Taylor Greene",
"district": "GA14",
"owner": "",
"assetDescription": "Novo Nordisk A/S Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030996.pdf"
},
{
"symbol": "NVO",
"senateID": "G000596",
"disclosureDate": "2025-08-21",
"transactionDate": "2025-08-19",
"firstName": "Marjorie Taylor",
"lastName": "Greene",
"office": "Marjorie Taylor Greene",
"district": "GA14",
"owner": "",
"assetDescription": "Novo Nordisk A/S Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030944.pdf"
},
{
"symbol": "NVO",
"senateID": "F000472",
"disclosureDate": "2025-08-15",
"transactionDate": "2025-08-04",
"firstName": "Scott",
"lastName": "Franklin",
"office": "Scott Mr Franklin",
"district": "FL18",
"owner": "",
"assetDescription": "Novo Nordisk A/S Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030918.pdf"
},
{
"symbol": "NVO",
"senateID": "F000472",
"disclosureDate": "2025-08-15",
"transactionDate": "2025-08-04",
"firstName": "Scott",
"lastName": "Franklin",
"office": "Scott Mr Franklin",
"district": "FL18",
"owner": "Spouse",
"assetDescription": "Novo Nordisk A/S Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030918.pdf"
},
{
"symbol": "NVO",
"senateID": "F000472",
"disclosureDate": "2025-08-15",
"transactionDate": "2025-08-04",
"firstName": "Scott",
"lastName": "Franklin",
"office": "Scott Mr Franklin",
"district": "FL18",
"owner": "",
"assetDescription": "Novo Nordisk A/S Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$15,001 - $50,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030918.pdf"
},
{
"symbol": "NVO",
"senateID": "M001136",
"disclosureDate": "2025-08-13",
"transactionDate": "2025-06-09",
"firstName": "Lisa C.",
"lastName": "McClain",
"office": "Lisa McClain",
"district": "MI09",
"owner": "Spouse",
"assetDescription": "Novo Nordisk A/S Common Stock",
"assetType": "Stock",
"type": "Purchase",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030891.pdf"
},
{
"symbol": "NVO",
"senateID": "M001136",
"disclosureDate": "2025-08-13",
"transactionDate": "2025-07-10",
"firstName": "Lisa C.",
"lastName": "McClain",
"office": "Lisa McClain",
"district": "MI09",
"owner": "Spouse",
"assetDescription": "Novo Nordisk A/S Common Stock",
"assetType": "Stock",
"type": "Sale (Partial)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030891.pdf"
},
{
"symbol": "NVO",
"senateID": "L000597",
"disclosureDate": "2025-06-23",
"transactionDate": "2025-05-08",
"firstName": "Laurel",
"lastName": "Lee",
"office": "Laurel Lee",
"district": "FL15",
"owner": "Spouse",
"assetDescription": "Novo Nordisk A/S Common Stock",
"assetType": "Stock",
"type": "Sale (Partial)",
"amount": "$1,001 - $15,000",
"capitalGainsOver200USD": "False",
"comment": "",
"link": "https://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030458.pdf"
}
],
"dark_pool": [
{
"ticker": "NVO",
"executed_at": "2026-10-07T09:26:54.971000Z",
"size": 860.0,
"price": 37.4,
"premium": 32164.0,
"volume": 860.0,
"trade_code": "F"
},
{
"ticker": "NVO",
"executed_at": "2026-10-07T10:10:04.810000Z",
"size": 600.0,
"price": 37.38,
"premium": 22428.0,
"volume": 600.0,
"trade_code": "F"
},
{
"ticker": "NVO",
"executed_at": "2026-10-07T10:10:04.810000Z",
"size": 600.0,
"price": 37.38,
"premium": 22428.0,
"volume": 600.0,
"trade_code": "F"
},
{
"ticker": "NVO",
"executed_at": "2026-10-07T10:10:04.810000Z",
"size": 600.0,
"price": 37.38,
"premium": 22428.0,
"volume": 600.0,
"trade_code": "F"
},
{
"ticker": "NVO",
"executed_at": "2026-10-07T09:15:51.987000Z",
"size": 496.0,
"price": 37.35,
"premium": 18525.600000000002,
"volume": 496.0,
"trade_code": " "
},
{
"ticker": "NVO",
"executed_at": "2026-10-07T09:56:42.465000Z",
"size": 420.0,
"price": 37.46,
"premium": 15733.2,
"volume": 420.0,
"trade_code": "F"
},
{
"ticker": "NVO",
"executed_at": "2026-10-07T10:28:56.363000Z",
"size": 350.0,
"price": 37.41,
"premium": 13093.499999999998,
"volume": 350.0,
"trade_code": "F"
},
{
"ticker": "NVO",
"executed_at": "2026-10-07T10:27:43.814000Z",
"size": 350.0,
"price": 37.3926,
"premium": 13087.41,
"volume": 350.0,
"trade_code": " "
}
],
"ats": {
"symbol": "NVO",
"date": "20261006",
"ats_volume": 0,
"total_volume": 5449980,
"ats_ratio": 0.0,
"ats_pct": 0.0,
"signal": "Low",
"history": [
{
"date": "20261006",
"ats_ratio": 0.0
},
{
"date": "20261005",
"ats_ratio": 0.0
},
{
"date": "20261002",
"ats_ratio": 0.0
},
{
"date": "20261001",
"ats_ratio": 0.0
},
{
"date": "20260930",
"ats_ratio": 0.0
}
]
},
"polygon_dp": {
"ticker": "NVO",
"days": [
{
"date": "2026-10-06",
"close": 37.53,
"vwap": 37.27,
"volume": 13696527,
"vwap_discount_pct": -0.69
},
{
"date": "2026-10-05",
"close": 37.54,
"vwap": 37.3,
"volume": 18700717,
"vwap_discount_pct": -0.64
},
{
"date": "2026-10-02",
"close": 37.32,
"vwap": 37.37,
"volume": 10261230,
"vwap_discount_pct": 0.13
},
{
"date": "2026-10-01",
"close": 37.4,
"vwap": 37.57,
"volume": 12656899,
"vwap_discount_pct": 0.46
},
{
"date": "2026-09-30",
"close": 37.91,
"vwap": 38.16,
"volume": 21556020,
"vwap_discount_pct": 0.67
}
],
"avg_vwap_discount_pct": -0.01,
"signal": "Neutral"
},
"options_flow": [
{
"underlying_symbol": "NVO",
"implied_volatility": "0.2651017254065296",
"size": 14,
"volume": 18,
"price": "18.07",
"strike": "20",
"underlying_price": "37.455",
"nbbo_ask": "18.45",
"sector": "Healthcare",
"option_chain_id": "NVO270617C00020000",
"expiry": "2027-06-17",
"delta": "0.998993415210792",
"option_type": "call",
"open_interest": 680,
"nbbo_bid": "17.70",
"executed_at": "2026-10-06T19:52:05.336000Z",
"premium": "25298.00"
},
{
"underlying_symbol": "NVO",
"implied_volatility": "1.672647778562093",
"size": 14,
"volume": 18,
"price": "12.37",
"strike": "25",
"underlying_price": "37.455",
"nbbo_ask": "12.75",
"sector": "Healthcare",
"option_chain_id": "NVO261016C00025000",
"expiry": "2026-10-16",
"delta": "0.945490771797221",
"option_type": "call",
"open_interest": 22,
"nbbo_bid": "11.90",
"executed_at": "2026-10-06T19:52:05.336000Z",
"premium": "17318.00"
},
{
"underlying_symbol": "NVO",
"implied_volatility": "0.3955519387575144",
"size": 20,
"volume": 87,
"price": "8.30",
"strike": "30",
"underlying_price": "37.5",
"nbbo_ask": "8.30",
"sector": "Healthcare",
"option_chain_id": "NVO270115C00030000",
"expiry": "2027-01-15",
"delta": "0.891258140707725",
"option_type": "call",
"open_interest": 2562,
"nbbo_bid": "8.25",
"executed_at": "2026-10-06T19:56:02.969000Z",
"premium": "16600.00"
},
{
"underlying_symbol": "NVO",
"implied_volatility": "0.3422802657792497",
"size": 10,
"volume": 20,
"price": "13.50",
"strike": "25",
"underlying_price": "37.5",
"nbbo_ask": "13.50",
"sector": "Healthcare",
"option_chain_id": "NVO270617C00025000",
"expiry": "2027-06-17",
"delta": "0.952713125920969",
"option_type": "call",
"open_interest": 12290,
"nbbo_bid": "13.45",
"executed_at": "2026-10-06T19:56:02.969000Z",
"premium": "13500.00"
}
],
"net_premium": {
"ticker": "NVO",
"net_call_premium": "-993004.00",
"net_put_premium": "426867.00",
"call_premium": "3473982.00",
"put_premium": "4736803.00",
"bullish_premium": "2099453.00",
"bearish_premium": "3519324.00",
"put_call_ratio": "0.4969082477039192507047376557",
"iv_rank": "31.4164",
"implied_move_perc": "0.08",
"gex_ratio": "1.6828288227252578",
"gex_net_change": "4369.0781",
"gex_call": "1950972.0443",
"gex_put": "-3190694.3384",
"gex_net": -1239722.2941,
"gex_call_delta": "17459930.3402",
"gex_put_delta": "-30860992.1009",
"gex_date": "2026-10-07"
},
"hot_chains": [
{
"open_interest": 3930,
"volume": 2057,
"last_price": "3.40",
"option_symbol": "NVO270319P00037500",
"ask_volume": 330,
"bid_volume": 1653,
"nbbo_bid": "3.30",
"nbbo_ask": "3.45",
"avg_price": "3.5237530384054448225571220224"
},
{
"open_interest": 3894,
"volume": 1801,
"last_price": "0.50",
"option_symbol": "NVO270617C00065000",
"ask_volume": 6,
"bid_volume": 1747,
"nbbo_bid": "0.46",
"nbbo_ask": "0.55",
"avg_price": "0.4619711271515824541921154914"
},
{
"open_interest": 29535,
"volume": 1083,
"last_price": "0.19",
"option_symbol": "NVO270115C00055000",
"ask_volume": 111,
"bid_volume": 848,
"nbbo_bid": "0.18",
"nbbo_ask": "0.21",
"avg_price": "0.1724653739612188365650969529"
},
{
"open_interest": 1036,
"volume": 1001,
"last_price": "3.35",
"option_symbol": "NVO280616C00055000",
"ask_volume": 1,
"bid_volume": 0,
"nbbo_bid": "3.05",
"nbbo_ask": "3.75",
"avg_price": "3.4399100899100899100899100900"
},
{
"open_interest": 1002,
"volume": 1000,
"last_price": "17.31",
"option_symbol": "NVO280616P00052500",
"ask_volume": 0,
"bid_volume": 0,
"nbbo_bid": "16.40",
"nbbo_ask": "17.30",
"avg_price": "17.31"
},
{
"open_interest": 1100,
"volume": 945,
"last_price": "0.43",
"option_symbol": "NVO261009C00037500",
"ask_volume": 343,
"bid_volume": 267,
"nbbo_bid": "0.41",
"nbbo_ask": "0.45",
"avg_price": "0.3124021164021164021164021168"
},
{
"open_interest": 14579,
"volume": 895,
"last_price": "6.10",
"option_symbol": "NVO280121C00040000",
"ask_volume": 102,
"bid_volume": 759,
"nbbo_bid": "6.05",
"nbbo_ask": "6.70",
"avg_price": "5.9616983240223463687150837983"
},
{
"open_interest": 7109,
"volume": 819,
"last_price": "1.55",
"option_symbol": "NVO261218C00040000",
"ask_volume": 330,
"bid_volume": 459,
"nbbo_bid": "1.54",
"nbbo_ask": "1.60",
"avg_price": "1.4504395604395604395604395606"
}
],
"gamma_profile": {
"ticker": "NVO",
"spot": 37.41,
"date": "2026-10-07",
"flip_point": 25.76,
"net_gex": -1239722.29,
"call_walls": [
{
"strike": 40.0,
"gex": 502813.22
},
{
"strike": 45.0,
"gex": 203273.05
},
{
"strike": 50.0,
"gex": 184432.39
}
],
"put_walls": [
{
"strike": 40.0,
"gex": -662366.31
},
{
"strike": 35.0,
"gex": -551107.8
},
{
"strike": 37.5,
"gex": -429163.35
}
],
"by_strike": [
{
"strike": 31.0,
"call_gex": 35.16,
"put_gex": -33.08,
"net_gex": 2.08
},
{
"strike": 32.0,
"call_gex": 31.42,
"put_gex": -320.45,
"net_gex": -289.03
},
{
"strike": 32.5,
"call_gex": 11969.26,
"put_gex": -48968.89,
"net_gex": -36999.63
},
{
"strike": 33.0,
"call_gex": 3.28,
"put_gex": -566.04,
"net_gex": -562.75
},
{
"strike": 33.5,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 34.0,
"call_gex": 199.27,
"put_gex": -8234.55,
"net_gex": -8035.29
},
{
"strike": 34.5,
"call_gex": 0.0,
"put_gex": 0.0,
"net_gex": 0.0
},
{
"strike": 35.0,
"call_gex": 91256.97,
"put_gex": -551107.8,
"net_gex": -459850.84
},
{
"strike": 35.5,
"call_gex": 95.7,
"put_gex": -4407.79,
"net_gex": -4312.09
},
{
"strike": 36.0,
"call_gex": 3880.7,
"put_gex": -360663.54,
"net_gex": -356782.84
},
{
"strike": 36.5,
"call_gex": 14215.51,
"put_gex": -21384.98,
"net_gex": -7169.47
},
{
"strike": 37.0,
"call_gex": 35127.28,
"put_gex": -210550.63,
"net_gex": -175423.35
},
{
"strike": 37.5,
"call_gex": 128170.53,
"put_gex": -429163.35,
"net_gex": -300992.82
},
{
"strike": 38.0,
"call_gex": 66213.38,
"put_gex": -108700.44,
"net_gex": -42487.06
},
{
"strike": 38.5,
"call_gex": 41679.01,
"put_gex": -156628.49,
"net_gex": -114949.49
},
{
"strike": 39.0,
"call_gex": 58267.01,
"put_gex": -47145.05,
"net_gex": 11121.96
},
{
"strike": 39.5,
"call_gex": 15927.56,
"put_gex": -4978.43,
"net_gex": 10949.13
},
{
"strike": 40.0,
"call_gex": 502813.22,
"put_gex": -662366.31,
"net_gex": -159553.08
},
{
"strike": 40.5,
"call_gex": 6341.16,
"put_gex": -786.0,
"net_gex": 5555.16
},
{
"strike": 41.0,
"call_gex": 37247.25,
"put_gex": -7056.03,
"net_gex": 30191.22
},
{
"strike": 41.5,
"call_gex": 5019.08,
"put_gex": -129.68,
"net_gex": 4889.4
},
{
"strike": 42.0,
"call_gex": 11014.67,
"put_gex": -3114.3,
"net_gex": 7900.36
},
{
"strike": 42.5,
"call_gex": 70723.72,
"put_gex": -102557.31,
"net_gex": -31833.59
},
{
"strike": 43.0,
"call_gex": 5974.79,
"put_gex": -1265.41,
"net_gex": 4709.38
},
{
"strike": 43.5,
"call_gex": 473.82,
"put_gex": 0.0,
"net_gex": 473.82
}
]
},
"oi_changes": {
"net_call_oi_change": -546,
"net_put_oi_change": 64,
"top": [
{
"strike": null,
"oi_change": -351,
"type": "call"
},
{
"strike": null,
"oi_change": -158,
"type": "call"
},
{
"strike": null,
"oi_change": 92,
"type": "call"
},
{
"strike": null,
"oi_change": -64,
"type": "call"
},
{
"strike": null,
"oi_change": -58,
"type": "call"
}
]
},
"opds": {
"opds": 13.6,
"D": 32.1,
"P": -39.3,
"O": 25.0,
"C": 42.4,
"signal": "NEUTRAL",
"direction": "bullish",
"coverage": 0.65,
"ranked": true,
"components": {
"M": -10.7,
"T": -100.0,
"RS": -70.0,
"V": 17.5,
"F": 100.0,
"OI": -100.0,
"S": null,
"IV": 100.0,
"B": null,
"Liquidity": 58.9,
"OpeningConfidence": 0.0,
"FlowAgreement": 66.7,
"StrikeBreadth": 50.0
},
"drivers": [
"+ aggressive flow +100",
"- open-interest change -100",
"+ IV behaviour +100",
"- trend -100",
"- relative strength -70"
]
}
}
Data:
{
"vix": 16.39,
"sp500": 7722.72,
"fed_funds": 3.63,
"yield_curve_10y2y": 0.45,
"hy_spread": 3.24,
"treasury": {
"date": "2026-10-05",
"month1": 4.05,
"month2": 4.13,
"month3": 4.22,
"month6": 4.3,
"year1": 4.47,
"year2": 4.84,
"year3": 4.97,
"year5": 5.06,
"year7": 5.19,
"year10": 5.31,
"year20": 5.7,
"year30": 5.66
},
"events": [
{
"title": "FOMC Meeting Minutes",
"currency": "USD",
"date": "2026-10-07",
"time_utc": "18:00",
"impact": "High",
"forecast": null,
"previous": null,
"actual": null,
"minutes_until": 392
}
]
}
Data:
{
"days": 88,
"patterns": [
{
"name": "VWAP Touch",
"count": 88,
"pct": 100
},
{
"name": "9 EMA Touch",
"count": 88,
"pct": 100
},
{
"name": "21 EMA Touch",
"count": 88,
"pct": 100
},
{
"name": "ORB Breakout",
"count": 87,
"pct": 99
},
{
"name": "Woodie Pivot Touch",
"count": 83,
"pct": 94
},
{
"name": "PDH/PDL Touch",
"count": 80,
"pct": 91
},
{
"name": "Open Retracement",
"count": 55,
"pct": 62
},
{
"name": "Gap Fill",
"count": 44,
"pct": 50
},
{
"name": "Darvas Box",
"count": 36,
"pct": 41
},
{
"name": "High Vol Open",
"count": 17,
"pct": 19
},
{
"name": "Power Hour",
"count": 13,
"pct": 15
}
]
}